NMPA Approval

Itopride Hydrochloride Tablets

Approval Number

国药准字H20010186

Registration Date

April 10, 2020

Drug Information

Generic Name

盐酸伊托必利片

Trade Name

瑞复啉

Brand Name

瑞复啉

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

April 10, 2020

Company Address

珠海市金湾区创业北路38号

Empowering clinical research with data-driven insights and AI-powered tools.

盐酸伊托必利片 - NMPA 批准文号 | MedPath